Faruqi & Faruqi, LLP reminds investors of the July 13, 2026 deadline to seek lead plaintiff in a securities class action against Phreesia, Inc. The lawsuit alleges the company and its executives made false and misleading statements about growth potential in its Network Solutions segment and the AccessOne acquisition, while concealing slowing demand and weaker pharmaceutical marketing commitments. After the market closed on March 30, 2026, Phreesia announced significantly reduced revenue growth projections for fiscal year 2027, citing worsening visibility and weaker pharmaceutical marketing commitments. The price of Phreesia’s common stock declined from a closing market price of $11.41 per share on March 30, 2025, to $8.38 per share on March 31, 2026, a decline of about 27%. Investors who purchased Phreesia securities between May 8, 2025 and March 30, 2026 may contact the firm to discuss their legal rights.
Phreesia IncSecurities class action lawsuit alleging false statements about growth and demand, leading to stock drop.